Cdk inhibitors (CKIs) may regulate the kinase activity of Cdk/cyclin complexes and generally function as tumor suppressors. Su et al. identified that lncRNA BLACAT1 was a critical player in the cell cycle of colorectal cancer via modulating the expression of P15 (a member of CKIs family) [23]. Here, BLACAT1 is linked to colorectal cancer.